Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study

Table 4 Preprocedural edoxaban interruption for major and nonmajor surgeries, excluding procedures without interruption

	Major surgeries		Nonmajor surgeries
Time of interruption relative to surgeries	Number of surgeries	Duration of preprocedural interruption, median^a	Number of surgeries	Duration of preprocedural interruption, median^a
Pre- and postprocedure interruption	160	3	114	2
Preprocedure interruption only	47	2	222	1
Postprocedure interruption only	13	NA	16	NA

The number of major and nonmajor surgeries that had no edoxaban interruption were 54 and 160 surgeries, respectively
NA Not applicable
^aThis table summarises data collected over the preprocedural window (days − 5 to 0); therefore, duration of interruption was not calculated for the postprocedure interruption

ISSN: 1477-9560